Evidence map›Paper›PMID 39688406›Full record

ArticlemSphere2025

Optimizing

Christina M Homer, Elena Ochoa, Mark Voorhies, Anita Sil

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Christina M HomerDivision of Infectious Diseases, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-4835-090X
Elena OchoaDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA.ORCID 0009-0007-8248-799X
Mark VoorhiesDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-8815-7384
Anita SilDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-3987-7534

Funding

Virulence gene discovery in CoccidioidesU19AI166798 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Anita Sil · 2022 to 2026
$10.5M
BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAMT32AI007641 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY · 2000 to 2026
$6.9M
Investigation of key proteases in the parasitic phase of CoccidioidesR21AI172185 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SIL, ANITA · 2022 to 2023
$444k
NIAID NIH HHS R21 AI172185NIAID NIH HHS T32 AI007641NIAID NIH HHS U19 AI166798
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoccidioidesSpores, FungalCarbonCoccidioidomycosisCulture MediaHyphaeNitrogenCarbonCulture MediaNitrogenarthroconidiaCoccidioidesdevelopmentfungal pathogenesismorphology

Identifiers

PMID39688406
PMCPMC11774042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.